Thermo Fisher Scientific

Thermo Fisher Scientific is proud of our Mission: To enable our customers to make the world healthier, cleaner, and safer. Thermo Scientific B·R·A·H·M·S investigates, develops, and manufactures novel testing to improve diagnosis and treatment of life-threatening diseases, like preeclampsia.

The PreClara Ratio (sFlt-1/PlGF) is the first FDA-cleared biomarker blood test aid in the risk assessment of pregnant women who have been hospitalized for hypertensive disorders of pregnancy to determine if they are at risk of progressing to preeclampsia with severe features within two weeks. The test is designed to be used along with other laboratory tests and clinical assessments.